MA

Mangal Akaram Gavali

Active Director Director DIN 07268564
DIN 07268564 First appointment Nov 2015 Primary industry Service
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2015
Shareholding value •••• Premium profile

About Mangal Akaram Gavali

Data last updated:

Mangal Akaram Gavali is a Director at Kartavya Pharmaceuticals Private Limited (since 2015). The company operates in Service. Kartavya Pharmaceuticals Private Limited reported revenue of ₹21,542 (FY 2021).

DIN 07268564
Primary Designation Director
Industry Service
First Appointment 09 Nov 2015
Oldest Company Age 11 yrs
Largest company Kartavya Pharmaceuticals Private Limited · ₹21,542 (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Nov 20152015₹21,542 (FY 2021)Active

Board colleagues of Mangal Akaram Gavali

Directorship timeline

Open interactive timeline →
Kartavya Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mangal Akaram Gavali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mangal Akaram Gavali

Mangal Akaram Gavali currently holds 1 directorship: Kartavya Pharmaceuticals Private Limited (Director, since 09 Nov 2015, revenue ₹21,542 (FY 2021)).

Mangal Akaram Gavali was first appointed on 09 Nov 2015 as Director at Kartavya Pharmaceuticals Private Limited.

The current boards of Mangal Akaram Gavali's companies include Shubhangi Snehalkumar Gavali (Kartavya Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available